logo

Seattle Genetics Inc. (SGEN)



Trade SGEN now with
  Date
  Headline
11/7/2019 8:08:24 AM Seattle Genetics Announces Multiple ADCETRIS Presentations
11/5/2019 8:06:58 AM Seattle Genetics, BeiGene Announce License Agreement For Advanced Preclinical Product Candidate For Treating Cancer
11/4/2019 11:56:59 PM Seattle Genetics Responds To Daiichi Sankyo's Complaint For Declaratory Judgment
10/29/2019 4:07:51 PM Seattle Genetics Q3 Loss Per Share $0.55 Vs Loss $0.42 Last Year
10/21/2019 6:48:17 AM Seattle Genetics Reports Positive Topline Results From HER2CLIMB trial
9/16/2019 8:02:47 AM Seattle Genetics And Astellas: FDA Grants Priority Review For Enfortumab Vedotin BLA
7/16/2019 4:05:52 PM Seattle Genetics Q2 Loss/share $0.49 Vs. Profit $0.47 Year Ago
7/16/2019 8:19:27 AM Astellas And Seattle Genetics Announce Submission Of Biologics License Application To FDA For Enfortumab Vedotin
7/16/2019 8:09:39 AM Seattle Genetics, Astellas Announce Submission Of BLA For Enfortumab Vedotin
  
 
>